Latest

Parkinson’s disease

·June 12, 2025·5 min read

Oral-Gut Bacteria Linked to Dementia Risk in Parkinson’s Disease

A new study has found that bacteria from the mouth may migrate to the gut and contribute to cognitive decline in people with Parkinson’s disease. Researchers identified harmful microbes and their toxins in the gut of Parkinson’s patients with dementia, suggesting a possible link between oral hygiene, gut health, and neurodegeneration.

Autism Featured Genetics Neurology Neuroscience

·May 29, 2025·5 min read

Link Found Between Autism and Early-Onset Parkinson’s Risk

A large-scale Swedish study has found that individuals with autism are at significantly higher risk of developing early-onset Parkinson’s disease. Researchers followed over two million people and discovered that those with autism were four times more likely to develop the neurodegenerative condition before age 50.

Featured Genetics Neurology Neuroscience

·May 10, 2025·4 min read

Exercise Boosts Stem Cell Therapy for Parkinson’s

Exercise enhances the effectiveness of stem cell-derived neuron transplants in a Parkinson’s disease (PD) rat model. Transplanted neurons alone improved basic motor functions, but when combined with voluntary exercise, the rats displayed significantly better agility and paw control.

This shows processed foods and the outline of a person.

Featured Neurology Neuroscience

·May 8, 2025·4 min read

Ultra Processed Foods May Accelerate Parkinson’s Brain Changes

A large new study shows that consuming high amounts of ultra processed foods may be linked to early indicators of Parkinson’s disease. Researchers tracked over 42,000 adults for up to 26 years, finding that those eating 11 or more daily servings of ultra processed foods were 2.5 times more likely to show multiple prodromal Parkinson’s symptoms.

This shows a person sitting and mushrooms.

Featured Neurology Neuroscience

·April 30, 2025·6 min read

Psilocybin Shows Promise for Parkinson’s Mood and Motor Symptoms

A new pilot study reveals that psilocybin—the compound found in psychedelic mushrooms—may significantly improve mood, cognition, and motor function in people with Parkinson’s disease. The compound was well tolerated, with only mild side effects, and benefits persisted for weeks after dosing. While the study was primarily designed to test safety, researchers observed meaningful and lasting improvements in multiple symptoms.

Featured Neuroscience

·April 29, 2025·7 min read

Brain’s Switching Mechanism Revealed: How We Rapidly Change Actions

New research shows that switching between actions is not simply stopping and starting again, but a unique brain mechanism that suppresses the previous action to initiate a new one. Using computational models, behavioral tasks, and clinical data from Parkinson’s patients, researchers found that stopping and switching are distinct cognitive motor processes.

Featured Genetics Neurology Neuroscience

·April 27, 2025·4 min read

New Biomarker Enables Early, Accurate Diagnosis of Parkinson’s

Researchers have identified a biomarker in spinal fluid that can detect Parkinson’s disease in its early stages with over 90% accuracy. Using a patented immuno-infrared sensor (iRS) technology, they measured the misfolding of the alpha-synuclein (αSyn) protein, a key driver of the disease.

Featured Neurology Neuroscience

·April 16, 2025·5 min read

AI Tool Predicts Toxic Protein Structures Behind Brain Disorders

A new AI tool called RibbonFold is revolutionizing how scientists understand misfolded proteins linked to Alzheimer’s and Parkinson’s. Unlike existing tools such as AlphaFold, which predict correctly folded proteins, RibbonFold is specifically designed to model the twisted, ribbonlike shapes of amyloid fibrils that accumulate in neurodegenerative diseases.

Brain Cancer Featured Genetics Neurology Neuroscience

·April 14, 2025·4 min read

Shared Protein Link Found Between Parkinson’s and Cancer

A new study reveals that the protein alpha-synuclein, known for its role in Parkinson’s disease, also contributes to the development of melanoma by promoting excessive DNA repair and cell proliferation. While in neurons, excess alpha-synuclein leads to cell death, in melanoma cells it enables uncontrolled growth by recruiting repair proteins to DNA breaks.

Featured Genetics Neuroscience

·April 12, 2025·5 min read

New Genes Linked to Parkinson’s Risk Revealed

Researchers have long wondered why some people with high-risk Parkinson’s gene variants develop the disease while others don’t. A new study has uncovered that additional genetic players, particularly the Commander gene complex, influence whether the disease manifests.

Autism Featured Genetics Neurology Neuroscience

·March 7, 2025·4 min read

Genetic Variant in ITSN1 Linked to Higher Parkinson’s and ASD Risk

A new study has identified genetic variants in the ITSN1 gene that significantly increase the risk of developing Parkinson’s disease. Researchers analyzed nearly 500,000 genetic profiles and found that individuals carrying ITSN1 variants face up to a tenfold higher risk of Parkinson’s.

Featured Neurology Neuroscience

·February 25, 2025·4 min read

FDA Approves Adaptive DBS for Parkinson’s Patients

The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms. Unlike traditional DBS, which delivers constant stimulation, aDBS monitors brain activity and responds with precise electric pulses to prevent stiffness and involuntary movements.